Lead Discovery Center GmbH - Product Pipeline Review - 2016

Lead Discovery Center GmbH - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Lead Discovery Center GmbH - Product Pipeline Review, 2016’, provides an overview of the Lead Discovery Center GmbH’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Lead Discovery Center GmbH, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Lead Discovery Center GmbH
  • The report provides overview of Lead Discovery Center GmbH including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Lead Discovery Center GmbH’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Lead Discovery Center GmbH’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Lead Discovery Center GmbH’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Lead Discovery Center GmbH
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Lead Discovery Center GmbH’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Lead Discovery Center GmbH Snapshot
Lead Discovery Center GmbH Overview
Key Information
Key Facts
Lead Discovery Center GmbH - Research and Development Overview
Key Therapeutic Areas
Lead Discovery Center GmbH - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Lead Discovery Center GmbH - Pipeline Products Glance
Lead Discovery Center GmbH - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Lead Discovery Center GmbH - Drug Profiles
Small Molecule for Target RhoGEF12 for Cardiovascular Disease
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Activate Beclin1 for Neurodegenerative Diseases and Viral Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit FKBP51 for Anxiety and Major Depressive Disorder
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Antagonize RON Kinase for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Cyclophilin for Immunology and Respiratory Disorders
Product Description
Mechanism of Action
R&D Progress
englerin A
Product Description
Mechanism of Action
R&D Progress
Small Molecule 1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule 2 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule 3 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule 4 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule for AMD, Inflammation and Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Amyotrophic Lateral Sclerosis
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Chlamydia Infections
Product Description
Mechanism of Action
R&D Progress
Small molecule for Multiple Sclerosis
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Activate TRIM32 for Neurodegenerative Diseases
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Agonize P2Y6R for Type 2 Diabetes
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Block TRPC4 and TRPC5 for Cardiovascular Disease and Epilepsy
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit AML1/ETO for Acute Myeloid Leukemia
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit CDK12 and CDK13 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Chemerin for Inflammation
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit degS Serine Endoprotease for Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit GLUT1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit GRK5 for Type 2 Diabetes
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit MARK2 for Alzheimer's Disease
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Plexin-B1/Sema4D for Multiple Sclerosis and Osteoporosis
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit RabGGTase for Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit SFRP1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Steroid Sulfatase for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Target Draxin for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Target Hedgehog Pathway for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Target K-Ras/PDE Delta for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Target Nrg1-ErbB4 Pathway for Schizophrenia and Cardiovascular Diseases
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Target SLC6A15 for Major Depressive Disorder
Product Description
Mechanism of Action
R&D Progress
Small Molecules 1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Charcot-Marie-Tooth Disease Type I A
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Influenza
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Lung Cancer
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Activate GFAT for Alzheimer’s Disease
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Agonize GPR81 for Atherosclerosis and Obesity
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit LRRK2 for Parkinson's Disease
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit NET Formation for Sepsis and SLE
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Target Notch Signaling Pathway for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Target SIRT7 for Cardiovacular Diseases, Metabolic Syndrome and Oncology
Product Description
Mechanism of Action
R&D Progress
Lead Discovery Center GmbH - Pipeline Analysis
Lead Discovery Center GmbH - Pipeline Products by Target
Lead Discovery Center GmbH - Pipeline Products by Molecule Type
Lead Discovery Center GmbH - Pipeline Products by Mechanism of Action
Lead Discovery Center GmbH - Recent Pipeline Updates
Lead Discovery Center GmbH - Dormant Projects
Lead Discovery Center GmbH - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Lead Discovery Center GmbH, Key Information
Lead Discovery Center GmbH, Key Facts
Lead Discovery Center GmbH - Pipeline by Indication, 2016
Lead Discovery Center GmbH - Pipeline by Stage of Development, 2016
Lead Discovery Center GmbH - Monotherapy Products in Pipeline, 2016
Lead Discovery Center GmbH - Partnered Products in Pipeline, 2016
Lead Discovery Center GmbH - Partnered Products/ Combination Treatment Modalities, 2016
Lead Discovery Center GmbH - Out-Licensed Products in Pipeline, 2016
Lead Discovery Center GmbH - Out-Licensed Products/ Combination Treatment Modalities, 2016
Lead Discovery Center GmbH - Preclinical, 2016
Lead Discovery Center GmbH - Discovery, 2016
Lead Discovery Center GmbH - Pipeline by Target, 2016
Lead Discovery Center GmbH - Pipeline by Molecule Type, 2016
Lead Discovery Center GmbH - Pipeline Products by Mechanism of Action, 2016
Lead Discovery Center GmbH - Recent Pipeline Updates, 2016
Lead Discovery Center GmbH - Dormant Developmental Projects,2016
ist of Figures
Lead Discovery Center GmbH - Pipeline by Top 10 Indication, 2016
Lead Discovery Center GmbH - Pipeline by Stage of Development, 2016
Lead Discovery Center GmbH - Monotherapy Products in Pipeline, 2016
Lead Discovery Center GmbH - Partnered Products in Pipeline, 2016
Lead Discovery Center GmbH - Out-Licensed Products in Pipeline, 2016
Lead Discovery Center GmbH - Pipeline by Top 10 Target, 2016
Lead Discovery Center GmbH - Pipeline by Molecule Type, 2016
Lead Discovery Center GmbH - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook